Arcadia Biosciences (RKDA) Non-cash Items (2014 - 2025)

Arcadia Biosciences has reported Non-cash Items for 12 years, with the latest figure at $108.2 million in Q3 2025.

• For the quarter ending Q3 2025, Non-cash Items rose 3347.01% year-over-year to $108.2 million; the trailing twelve-month figure through Sep 2025 stood at $108.2 million (up 3347.01% YoY), and the FY2024 full-year result was $516.4 million, up 1237178.06% from the prior year.
• Non-cash Items for Q3 2025 stood at $108.2 million, down from $261.6 million in the prior quarter.
• The five-year high for Non-cash Items was $516.4 million in Q4 2024, with the low at $29741.0 in Q1 2025.
• Historically, Non-cash Items has averaged $91.7 million across 5 years, with a median of $873633.0 in 2022.
• Annual changes were most pronounced in 2021 — Non-cash Items jumped 50041.7% — and 2022, when it tumbled 99.38%.
• Arcadia Biosciences' Non-cash Items stood at $501417.0 in 2021, then soared by 74.23% to $873633.0 in 2022, then slumped by 95.95% to $35364.0 in 2023, then surged by 1460079.84% to $516.4 million in 2024, then tumbled by 79.04% to $108.2 million in 2025.
• The last three Non-cash Items figures came in at $108.2 million (Q3 2025), $261.6 million (Q2 2025), and $29741.0 (Q1 2025), per Business Quant data.